Home
E-Submission
Sitemap
Contact Us
HOME
ABOUT
Aims and scope
About the journal
Editorial board
Principles of transparency and best practice
Management team
Open access
Subscription information
Contact us
BROWSE ARTICLES
All issues
Current issue
Ahead-of print articles
Most read articles
Most download articles
Most cited articles
Search
Author index
FOR AUTHORS AND REVIEWERS
Instructions for authors
Research and publication ethics
Author checklist
E-submission
Submission requirement form
Search
Search
Page Path
HOME
Search
Bladder Cancer
Invited Review
A Review of Emerging Neoadjuvant Intravesical Strategies to Enhance Systemic Immune Checkpoint Blockade in Patients With Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Through the Induction of Immunogenic Cell Death and Activation of Tertiary Lymphoid Structure formation
Hye Won Lee, Hyun Hwan Sung
Journal of Urologic Oncology.
2025;23(1):63-78. Published online March 31, 2025
DOI:
https://doi.org/10.22465/juo.255000300015
Cited By 1
Full text
PubReader
ePub
PDF
Kidney Cancer
Original Article
Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study
Joohyun Hong, Ghee Young Kwon, Minyong Kang, Seong Il Seo, Se Hoon Park
Journal of Urologic Oncology.
2024;22(1):59-67. Published online March 31, 2024
DOI:
https://doi.org/10.22465/juo.234600660033
Cited By 1
Full text
PubReader
ePub
PDF
Optimal Management for BCG Unresponsive Non-Muscle-Invasive Bladder Cancer
Invited Review
Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
Jiwoong Yu, Hyun Hwan Sung
Journal of Urologic Oncology.
2023;21(3):228-240. Published online November 30, 2023
DOI:
https://doi.org/10.22465/juo.234600420021
Cited By 2
Full text
PubReader
ePub
PDF
Trimodality Therapy and Immuno-Oncology for Bladder Cancer
Invited Review
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Sang Hun Song, Jong Jin Oh
Journal of Urologic Oncology.
2023;21(2):154-164. Published online July 31, 2023
DOI:
https://doi.org/10.22465/juo.234600300015
Cited By 3
Full text
PubReader
ePub
PDF
Original Article
De Ritis Ratio, Neutrophil-to-Lymphocyte Ratio, and Albumin Are Significant Prognostic Factors for Survival Even After Adjusted by the Treatment Duration in Metastatic Kidney and Bladder Cancer Treated With Immune-Checkpoint Inhibitors
Sung Han Kim, Eun Young Park, Hyung-Ho Lee, Jinsoo Chung, Ho Kyung Seo
Korean J Urol Oncol.
2022;20(1):25-33. Published online February 24, 2022
DOI:
https://doi.org/10.22465/kjuo.2022.20.1.25
Full text
PubReader
ePub
PDF
Review Article
New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
Jaewoon Jeong, Jae Baek Ha, In Ho Chang
Korean J Urol Oncol.
2022;20(1):12-24. Published online February 24, 2022
DOI:
https://doi.org/10.22465/kjuo.2022.20.1.12
Full text
PubReader
ePub
PDF
Review Article
The Systematic Review of the Efficacy and Safety of Immune Checkpoint Inhibitor in Urological Cancers
Gwang Yong Hwang, Se Young Choi, In Ho Chang
Korean J Urol Oncol.
2019;17(2):75-80. Published online August 30, 2019
DOI:
https://doi.org/10.22465/kjuo.2019.17.2.75
Full text
PubReader
ePub
PDF
1
Journal of
Urologic Oncology
Print ISSN: 2951-603X
Online ISSN: 2982-7043
MOST READ
MOST CITED
6,292
Complex Epidemiology of Prostate Cancer in Asian Countries
4,173
Current Update on Prostate Cancer Immunotherapy
4,051
Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023
3,846
Role of Radiotherapy in Metastatic Renal Cell Carcinomas: An Evolutionary Journey in a Misunderstood Histological Type
3,670
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
+more
Cited By
11
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By
10
Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By
3
The Evolving Role of Checkpoint Inhibitors in the Treatment of Urothelial Carcinoma: A Literature Review of Practice-Changing Trials
Cited By
3
Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
Cited By
3
Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review
+more